Hospice Services for Complicated Grief and Depression: Results from a National Survey

• Autores: Angela R. Ghesquiere, Melissa D. Aldridge, Rosemary Johnson Hürzeler, Daniel Kaplan, Martha L. Bruce, Elizabeth Bradley
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 63, Nº. 10, 2015, págs. 2173-2180
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Objectives To describe the prevalence of screening for complicated grief (CG) and depression in hospice and access to bereavement therapy and to examine whether screening and access to therapy varied according to hospice organizational characteristics or staff training and involvement.

    Design Cross-sectional national survey conducted from 2008 to 2009.

    Setting United States.

    Participants Hospices (N = 591).

    Measurements Whether hospices screened for depression or CG at the time of death or provided access to bereavement therapy (individual or group). Organizational characteristics included region, chain status, ownership, and patient volume. Staffing-related variables included training length and meeting attendance requirements.

    Results Fifty-five percent of hospices provided screening for CG and depression and access to bereavement therapy, 13% provided screening but not access to bereavement therapy, 24% provided access to bereavement therapy but not screening, and 8% neither screened nor provided access to bereavement therapy. Hospices with 100 patients per day or more were significantly more likely to provide screening and access to bereavement therapy.

    Conclusion Hospices appear to have high capacity to provide screening for CG and depression and to deliver group and individual therapy, but data are needed on whether screeners are evidence based and whether therapy addresses CG or depression specifically. Future work could build upon existing infrastructure to ensure use of well-validated screeners and evidence-based therapies.